4 percent of those aged 65+ have dementia diagnoses: report
By
Kimberly Bonvissuto
Jun 14, 2024
Four percent of US adults aged 65 or more years have a dementia diagnosis, with rates of dementia increasing with age, according to newly released data.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Navigating insurance for those with dementia a major challenge for family caregivers
By
Kathleen Steele Gaivin
Jan 30, 2024
Family caregivers face many challenges in helping their loved ones who are living with dementia, not the least of which is navigating the insurance landscape for long-term care. That’s according to the...
Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
This clue can help ID dementia years before a formal diagnosis
By
Lois A. Bowers
Jun 03, 2024
As scientists and physicians work to improve the lives of those living with dementia now and in the future, new research contributes to the list of signs and symptoms that we can look for in friends and...
New fluorescence imaging technique makes toxic Alzheimer’s proteins ‘glow’ for earlier-than-ever...
By
Aaron Dorman
Feb 08, 2024
An innovative sensor was able to detect toxic beta amyloid proteins, which cause Alzheimer’s, with a new fluorescence “fingerprint” technique.
More news for Monday, Feb. 5
By
Kimberly Bonvissuto
Feb 05, 2024
Takeaways from NIC MAP’s fourth-quarter fundamentals release … Use of Medicaid wraparound services by dually eligible individuals varies by service, state … StartUp Health launches global Alzheimer’s...
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Caregivers, seniors with Alzheimer’s to benefit from ‘Rippl’ effect, access to 24/7 helpline
By
Aaron Dorman
Apr 09, 2024
A new dementia care platform will get telehealth to more seniors, and their caregivers, including access to a 24/7 helpline.